Quantity of Factors
The surgeons noted that survival was the longest for patients with more of the described factors: 11% of patients had no factors, median survival was 18.5 months; 31% had 1 factor, median survival was 29.7 months; and 29% had 2 factors, median survival was 58.6 months.
Significantly, an additional 29% of patients had all 3 factors. 1 “For those 29% of patients with all 3 factors, the median (average) survival has not been met yet, meaning that more than 50% of participants are alive at the last follow-up, ie, nearly 80% were alive at the 5 year mark,” Dr Truty explained to Oncology Nurse Advisor. “Some of these patients were enrolled at the very start of our 7-year study.”
1. Truty MJ, Kendrick ML, Nagorney DM, et al. Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline/locally advanced pancreatic cancer [published online April 5, 2019]. Ann Surg. 2019 Apr 2. doi: 10.1097/SLA.0000000000003284